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Twisting tails exposed: the evidence for TCR 
conformational change
 
Susan E. Levin and Arthur Weiss
 
The mechanism by which the ligand occupancy state of the T cell receptor 
complex is converted into intracellular signaling information has been a 
controversial topic. Although the majority of structural studies argue against a 
conformational change, recent studies support the possibility for such a 
change within the CD3 components of the TCR complex. In this commentary, 
the evidence for TCR conformational change is reviewed and potential 
mechanisms for its initiation are explored.
 
Although a great deal is known about
the details of TCR signaling, how it is
initiated continues to be a topic of in-
tense debate. The TCR complex con-
sists of the 
 
  
 
 heterodimer, the associ-
ated CD3 chains (dimers of 
 
  
 
 and
 
  
 
), and the 
 
 
 
 homodimer. The 
 
  
 
chains engage antigenic peptides bound
to the major histocompatibility complex
(pMHC), whereas the CD3 and 
 
 
 
chains function as the signaling com-
ponents through their immunoreceptor
tyrosine-based activation motifs (ITAMs)
located in their cytoplasmic domains.
The structure of the TCR complex
requires that the ligand-binding com-
ponents somehow communicate to the
signaling chains on the cytoplasmic side
of the membrane upon appropriate in-
teraction with pMHC.
Many models have been proposed
for how TCR signaling is initiated, in-
cluding TCR oligomerization and con-
formational change. The oligomeriza-
tion model has received much support
based on the ability of anti-TCR anti-
bodies to cross-link and thereby stimulate
T cells (1). Furthermore, T cell activation
can be mimicked by antibody treatment
of chimeric T cell receptors that contain
extracellular domains of other mole-
cules linked to CD3 or 
 
 
 
-containing
ITAM sequences, suggesting that cluster-
ing of the molecules is sufficient for
triggering activation. However, this clus-
tering model does not account for the
great sensitivity of the TCR complex.
For instance, it has been shown that a
small number of peptides, even one
pMHC complex, can initiate signaling
events (2). Under these circumstances,
conformational change in the TCR is a
more attractive model. Conformational
change has also been proposed to ex-
plain early studies of TCR signaling
where receptor multimerization or the
avidity of antibodies for the receptor do
not sufficiently explain the biochemical
results (3). For example, analyses of
panels of antibodies against the TCR
demonstrated that the ability of the
antibody to induce TCR signal trans-
duction or activation was epitope de-
pendent (4, 5). Neither avidity nor
cross-linking appeared to fully account
for the differential stimulatory abilities of
the antibodies, thereby lending support
for a role for conformational change.
 
Conformational change within 
the 
 
  
 
 heterodimer
 
In general, analyses of crystal structures
of TCR–pMHC complexes have argued
against the idea of a large conforma-
tional change within the 
 
  
 
 chains
upon ligand engagement. The confor-
mational change that has been deduced
from ligand-bound and ligand-free re-
ceptors occurs within the complemen-
tarity-determining regions (CDRs) of
the TCR, which associate with pMHC,
but not in the distal portions of the
heterodimer which are adjacent to the
cell membrane (6). The movement in
the binding site supports an “induced
fit” model of TCR–pMHC engage-
ment where adjustments in the CDR
loops are made to accommodate the
peptide presented by MHC, but these
adjustments do not appear to be trans-
mitted to the associated CD3 and 
 
 
 
molecules (6, 7). However, it is impor-
tant to note the limitations of the avail-
able structural data. Currently, only the
ectodomains of the TCR components
have been studied in isolation. It is well
documented that the transmembrane
regions of the TCR are essential for
proper TCR assembly (8), and thus the
CD3 chains may influence or constrain
the structural arrangement of the 
 
  
 
heterodimer. The conformation of the
receptor based on crystal structures can-
not be appreciated until the entire TCR
complex is studied as one functional
unit.
Although the majority of the avail-
able structural data does not support a
conformational change model, recent
data complicates the debate. Interest-
ingly, the crystal structure of the LC13
TCR with its ligand, an Epstein-Barr
virus peptide–MHC molecule, com-
pared with the unligated receptor, re-
veals that a large conformational change
occurs in the constant domain of TCR
 
 
 
(9). However, it is unknown how ap-
plicable this structural change is to
other TCRs.
 
Conformational change within the CD3 
and 
 
 
 
 chains
 
Despite the relative lack of consistent
data regarding conformational change
within the 
 
  
 
 heterodimer, there is in-
creasing evidence that conformational
change does occur within the associ-
ated CD3 chains of the TCR. This
idea is intriguing from a signaling per-
spective because the ITAMs in the cy-
toplasmic domains of these components
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are the proximal targets of tyrosine
phosphorylation. Once they are dou-
bly phosphorylated by the Src family
kinase Lck, the Syk tyrosine kinase
ZAP-70 is recruited and then promotes
the downstream signaling cascade (10).
Therefore, alterations in the cytoplas-
mic tails of the CD3 chains could dra-
matically affect the availability of the
ITAMs and other domains and thus
regulate signaling initiation.
The structural regulation of the sig-
naling domains was first proposed for
the 
 
 
 
 chain, whose cytoplasmic tail was
shown to be differentially available to
phosphorylation by Src family kinases
based on local environment (11). In the
presence of lipids, the cytoplasmic do-
main of the 
 
 
 
 chain was folded and in-
capable of being phosphorylated, whereas
in aqueous solution the domain was
unstructured and readily phosphory-
lated (Fig. 1 A). Although there are no
cellular data available supporting these
findings, it was suggested that TCR
clustering leads to an increase in local 
 
 
 
concentration and, consequently, com-
petition for membrane binding, thereby
resulting in the release of the cytoplas-
mic domains of 
 
 
 
 from the membrane.
The cytoplasmic domains could also be
rearranged by some other mechanism
that is not clustering dependent as de-
scribed later.
More recently, the conformational
change debate has shifted its focus to
the cytoplasmic tail of CD3
 
 
 
. In 2002,
Alarcón and colleagues reported that
upon engagement with certain anti-
TCR antibodies or anti-CD3
 
 
 
 anti-
bodies the proline-rich sequence in the
cytoplasmic tail of CD3
 
 
 
 becomes ac-
cessible, and this was interpreted to re-
flect a conformational change (refer-
ence 12; Fig. 1 B). The exposure of the
proline-rich sequence was detected by
the ability of CD3
 
 
 
 to inducibly bind
the SH3.1 domain of the adaptor pro-
tein Nck. Nck was also recruited to the
TCR upon antigen treatment of TCR
transgenic T cells. The exposure of the
motif occurred independently of and
before any tyrosine phosphorylation,
thereby suggesting that a TCR con-
formational change preceded TCR sig-
naling. In addition, lateral movement
within membranes was not required
since the CD3
 
 
 
 proline-rich motif was
exposed when cells were stimulated on
ice. Perhaps most interestingly, this pu-
tative conformational change was not
observed with all antibodies used for
stimulation. Moreover, a monovalent
Fab fragment was able to expose the
CD3
 
 
 
 motif, suggesting that the TCR
cross-linking did not induce the alter-
ation in the cytoplasmic domain. Al-
though their data convincingly demon-
strated that the proline-rich sequence
is differentially exposed upon ligand
treatment, the specific events leading to
this accessibility of the CD3
 
 
 
 sequence,
the role of Nck itself, and the biological
relevance of the conformational change
remain unclear. Overexpression of the
SH3.1 domain of Nck appeared to act
as a dominant negative by inhibiting
complete TCR activation and proper
cytoskeleton rearrangement. But clearly
such overexpression is subject to sig-
nificant artifacts as there may be many
targets of this domain, and the binding
of this region to the CD3
 
 
 
 sequence
could disrupt other relevant interac-
tions. Nonetheless, exposure of the mo-
tif suggests previously unappreciated
movements in the TCR complex.
In this issue, Palmer and colleagues
extend the study of CD3
 
 
 
 conforma-
tional change to murine thymocytes
and peptide ligands (13). In ex vivo
studies of OT-I TCR transgenic CD4
 
 
 
CD8
 
 
 
 thymocytes, both positively and
negatively selecting peptides expose the
proline-rich region in CD3
 
 
 
. The con-
formational change occurred indepen-
dently of enzymatic and cellular activ-
ity as was seen for Jurkat T cells (12). In
addition, Gil et al. impressively dem-
onstrate the exposure of the proline-
Figure 1. Potential mechanism for induced exposure of the proline-rich motif in CD3 . 
The TCR complex is represented as a tight bundle as suggested by the recent model (23). (A) Prior to 
ligand binding, the cytoplasmic domains of   (red chains) could block the motif in CD3 , which would 
become more accessible upon interaction with pMHC (11). (B) Alternatively, movement in CD3  itself 
could lead to exposure of the proline motif (12).
 
20050179  Page 490  Thursday, February 10, 2005  2:30 PM 
JEM VOL. 201, February 21, 2005
 
491
 
COMMENTARY
 
rich region in thymocytes upon en-
gagement with endogenous thymic
ligands. Their detailed analysis of the
CD3
 
 
 
 conformational change in a pep-
tide-dependent manner lends support
for a potential role for a conformational
change.
The finding that both positively
and negatively selecting ligands were
capable of equivalently exposing the
motif in CD3
 
 
 
 indicates that confor-
mational change is not the discrimi-
nating factor in selection or for dis-
tinguishing agonist from antagonist.
However, since peptides that do not
function as ligands for the TCR did
not induce a conformational change,
some productive interaction is required
to expose the proline motif. In this
way, affinity itself does not appear to
be a key factor in mediating confor-
mational change. This is interesting
when considering the previous struc-
tural studies of the A6 TCR interaction
with altered peptide ligands (14). Inter-
actions with both weak agonist and
antagonists were very similar in struc-
ture to that of a strong agonist. These
results were interpreted as providing
evidence against a conformational change,
but that assumed that altered peptide
ligands would induce significantly dif-
ferent alterations in structure. Together,
the structural and new biochemical
data suggest that exposure of the pro-
line motif in CD3
 
 
 
 alone is not suffi-
cient for determining qualitative and/
or quantitative differences in T cell
signaling.
 
Potential mechanisms for induction of 
CD3 conformational change
 
Although there are strong data support-
ing a conformational change in the
CD3 cytoplasmic domains, the ques-
tion remains how the change occurs
upon ligand engagement. As discussed
above, with the exception of the LC13
TCR crystal structure, most structural
studies do not demonstrate a change in
the membrane-proximal regions of the
 
  
 
 heterodimer (9). However, a recent
thermodynamic study, where change
in heat capacity (a measure of binding
energetics) correlates with conforma-
tional change or TCR flexibility, sup-
ports a role for conformational change
(15). All but one of the analyzed pep-
tides induced a conformational change
in the TCR complex. Interestingly, the
combination of half-life and conforma-
tional change and/or flexibility best
predicted the level of T cell activation.
Although the observed changes in heat
capacity could be due strictly to changes
in CDR3 loops, the recorded confor-
mational change did have an impact on
signaling outcome, based on IL-2 pro-
duction by transgenic TCR T cells,
suggesting that the change was some-
how transmitted to the CD3 com-
plex or 
 
 
 
.
One mechanism to explain the al-
terations in CD3 is the piston model,
which has been suggested for the bacte-
rial aspartate receptor (16). A similar
piston-like movement of the TCR or
its rotation could make the cytoplasmic
domains of the CD3 chains differen-
tially accessible (12, 17, 18). For in-
stance, structural rearrangement of the 
 
 
 
chain could play a role in rendering the
CD3
 
 
 
 chain and proline motif more ac-
cessible (11) (Fig. 1 A). Support for this
comes from 
 
 
 
-deficient mice reconsti-
tuted with 
 
 
 
 truncations. Truncation of
 
 
 
 led to markedly increased phosphory-
lation of the CD3 chains after receptor
stimulation (19). There is also some re-
cent data to suggest that 
 
 
 
 may dissoci-
ate from the TCR complex or undergo
conformational alterations after TCR
ligation (20). In addition, according to
this piston model, the conformational
change in the A-B loop of the constant
domain of TCR
 
 
 
 observed for the
LC13 TCR could potentially lead to
exposure of the proline-rich region of
CD3
 
 
 
 (9) (Fig. 1 B).
Although the TCR complex is of-
ten represented schematically as distinct
units, biochemical studies have shown
that the chains are associated and func-
tionally coupled by their acidic and ba-
sic residue-containing transmembrane
domains (8, 21). Biochemical studies
support three-helix interactions between
the transmembrane residues, where
TCR
 
 
 
 associates with CD3
 
  
 
 and the
 
 
 
 homodimer, whereas TCR
 
 
 
 associ-
ates with CD3
 
  
 
, supporting older
cross-linking studies (8, 22). Recently,
the ectodomain structure of the
CD3
 
  
 
 was published, thereby com-
pleting the structural analysis of the ex-
tracellular domains of the TCR com-
plex (23). The authors of that study
combined all of the available structural
information and proposed a model in
which the tight transmembrane asso-
ciation is reinforced by conserved ecto-
domain associations. They further hy-
pothesized that the CD3 subunits sit
under the constant domains of the
TCR heterodimer loops because the
majority of the CD3 dimers are inac-
cessible (Fig. 1). If the TCR complex is
so tightly associated, it is clearly possi-
ble that small alterations that are in-
duced upon ligand binding could be
transmitted across the membrane to ex-
pose the proline-rich region in CD3
 
 
 
directly or via a 
 
 
 
 conformational change
(Fig. 1).
 
Conclusion
 
The recent studies of the TCR complex
suggest that ligand-induced conforma-
tional change does occur. However, the
induction of this conformational change
alone is not sufficient for T cell activa-
tion. Recent thermodynamic studies
and the new study in this issue by
Palmer and colleagues suggest that con-
formational change and other factors
can account for signaling initiation and
outcome (13, 15). Therefore, it remains
to be seen how this conformational
change contributes to T cell activation.
Perhaps the conformational change is a
prerequisite for ITAM phosphorylation,
and some other unknown factor deter-
mines the persistence of phosphoryla-
tion and thus signaling potential. Future
studies should concentrate on determin-
ing the mechanism for CD3
 
 
 
 confor-
mational change and elucidating its bio-
logical relevance via mutagenesis of the
proline-rich sequence.
 
We thank Jeroen Roose for his assistance in preparing 
the figure.
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